Treatment of Intermittent Explosive Disorder With Carbamazepine

Clin Neuropharmacol. 2018 Mar/Apr;41(2):82-83. doi: 10.1097/WNF.0000000000000276.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenergic Uptake Inhibitors / therapeutic use
  • Antidepressive Agents / therapeutic use
  • Antimanic Agents / therapeutic use*
  • Antipsychotic Agents / therapeutic use
  • Atomoxetine Hydrochloride / therapeutic use
  • Attention Deficit Disorder with Hyperactivity / complications
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Carbamazepine / therapeutic use*
  • Child
  • Depression / drug therapy
  • Disruptive, Impulse Control, and Conduct Disorders / complications
  • Disruptive, Impulse Control, and Conduct Disorders / drug therapy*
  • Dopamine Uptake Inhibitors / therapeutic use
  • Humans
  • Male
  • Methylphenidate / therapeutic use
  • Risperidone / therapeutic use
  • Sertraline / therapeutic use

Substances

  • Adrenergic Uptake Inhibitors
  • Antidepressive Agents
  • Antimanic Agents
  • Antipsychotic Agents
  • Dopamine Uptake Inhibitors
  • Methylphenidate
  • Carbamazepine
  • Atomoxetine Hydrochloride
  • Risperidone
  • Sertraline